KalVista Pharmaceuticals
KALV
KALV
122 hedge funds and large institutions have $561M invested in KalVista Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 119 → 122 (+3)
1% less capital invested
Capital invested by funds: $568M → $561M (-$7.25M)
2.31% less ownership
Funds ownership: 114.33% → 112.01% (-2.3%)
Holders
122
Holding in Top 10
4
Calls
$5.82M
Puts
$1.36M
Top Buyers
| 1 | +$19.7M | |
| 2 | +$5.97M | |
| 3 | +$5.3M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$2.32M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$2.22M |
Top Sellers
| 1 | -$8.68M | |
| 2 | -$8.16M | |
| 3 | -$7.3M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$6.62M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$6.31M |